Director's Dealing • Jul 2, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 3254T
CVS Group plc
02 July 2018
2 July 2018
CVS Group plc
("CVS" or the "Company")
Director/PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services, announces that today, 2 July 2018, Deborah Kemp, non-executive director, purchased 6,559 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares").
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Deborah Kemp
2
Reason for the notification
a)
Position/status
Non-executive director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| i. 1,140p | i. 6,559 |
d)
Aggregated information
- Aggregated volume
- Price
n/a
e)
Date of the transaction
i. 02 July 2018
f)
Place of the transaction
i. London Stock Exchange (XLON)
Contacts:
CVS Group plc
Simon Innes, Chief Executive
Nick Perrin, Finance Director
Tel: 01379 644 288
N+1 Singer (Nominated Adviser & Broker)
Aubrey Powell
Liz Yong
Tel: 020 7496 3000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEASXAESEPEFF
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.